Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing stent treatments for chronic mesenteric ischemia

Official title: Copenhagen Mesenteric Stent Study - A Randomized Trial of Stent Versus Covered Stent Treatment for Chronic Mesenteric Ischemia

Run by Copenhagen University Hospital, Rigshospitalet · NCT05244629 · Data updated 2026-11-12

This study is testing whether covered stents work better than bare metal stents for people with chronic mesenteric ischemia to see which one helps them more after a year.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment98 (estimated)
SponsorCopenhagen University Hospital, Rigshospitalet
Academic / other
Locations1 site (København Ø)
StatusRecruiting
StartedJune 2023
Main results expectedAugust 2024
Study endsAugust 2029
Registry record updatedJune 12, 2023
Trial IDNCT05244629 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 with symptomatic chronic mesenteric ischemia due to significant atherosclerotic stenosis.

Probably not a fit

Patients with non-atherosclerotic causes of mesenteric ischemia or those experiencing acute mesenteric ischemia will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial evaluates the effectiveness of bare metal stents (BMS) versus covered stents (CS) in treating chronic mesenteric ischemia (CMI), a condition caused by narrowed arteries supplying blood to the intestines. Patients with significant stenosis of the superior mesenteric artery will be randomly assigned to receive either type of stent. The primary outcome measured will be stent patency one year after placement, along with assessments of complications, reoperation rates, quality of life, and mortality reasons. The study aims to provide clearer evidence on the benefits of using covered stents over bare stents.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment options for patients with chronic mesenteric ischemia, potentially reducing symptoms and recurrence rates.

How similar studies have gone: While the use of covered stents is increasingly supported, the level of evidence is limited, indicating that this approach is still being evaluated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with symptomatic CMI of atherosclerotic or atherothrombotic etiology
* Intended endovascular treatment
* Symptoms consistent with CMI (pain, weight loss, diarrhea)
* Significant ostial stenosis (\>50%) of the superior mesenteric artery on CTA
* Significant stenosis on angiography (\>50% or \>15mmHg pressure gradient)
* Patients \> 18 years

Exclusion Criteria:

* No informed consent
* Non atherosclerotic cause of MI
* Acute mesenteric ischemia (AMI)
* Signs of acute bowel ischemia, peritonitis, laparotomy, sepsis
* Previous stent treatment in the superior mesenteric artery(ies)
* Target artery lesions \>4cm in length
* Unable to cross lesion with guidewire
* Non-significant stenosis angiographically
* Pregnancy
* Allergies to contrast media or stent materials

Where it's running

  • Department of Vascular Surgery, Heart Center, Copenhagen University Hospital - Rigshospitalet
    København Ø, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.